2009Yixue yanjiusheng xuebaoRequires access

Inhibition of A549 cell proliferation by RNA interfered gene her2/neu

Fang Zhang

Open publisher page 0 citations

Abstract

Objective:The effect of HER2/neu expression on the proliferation of A549 cell is not clear. We inhibited the HER2/neu expression with RNA interference (RNAi) technique,and investigated the proliferation of A549 cell in this study. Methods:Firstly a recombinant RNAi expression plasmid targeting to her2/neu gene (named psilence 3.1-HER2) was constructed. After RNAi plasmids being transfected to A549 cells with Lipofectamine,the positive clones were screened with G418. The expression changes of HER2/neu mRNA and protein were evaluated with RT-PCR and Western Blot respectively; Also FCM analysis,MTT method were applied to measure cell cycle,cell growth of A549 cell respectively after the transfection of psilence 3.1-HER2. Results:The psilence 3.1-HER2 was successfully constructed and can specially inhibit HER2/neu mRNA and protein expression after transfection. FCM results showed that cells transfected with psilence 3.1-HER2 increased accumulation of cells in G0/G1 phase with a decrease in the percentage of cells in S-phase,and the growth curve of cells exhibited slower proliferation. Conclusion:The psilence 3.1-HER2 can knockdown her2/neu gene specially and efficiently,transfection of psilence 3.1-HER2 contributes to the depression of A549 cell proliferation. The data described here provided a proof of the concept that vector-based RNAi targeting to her2/neu gene could be used therapeutically for lung cancer.

About this research paper

What this paper is about

Objective:The effect of HER2/neu expression on the proliferation of A549 cell is not clear. We inhibited the HER2/neu expression with RNA interference (RNAi) technique,and investigated the proliferation of A549 cell in this study. Methods:Firstly a recombinant RNAi expression plasmid targeting to her2/neu gene (named psilence 3.1-HER2) was constructed. After RNAi plasmids being transfected to A549 cells with Lipofectamine,the positive clones were screened with G418. The expression changes of HER2/neu mRNA and protein were evaluated with RT-PCR and Western Blot respectively; Also FCM analysis,MTT method were applied to measure cell cycle,cell growth of A549 cell respectively after the transfection of psilence 3.1-HER2. Results:The psilence 3.1-HER2 was successfully constructed and can specially inhibit HER2/neu mRNA and protein expression after transfection. FCM results showed that cells transfected with psilence 3.1-HER2 increased accumulation of cells in G0/G1 phase with a decrease in the percentage of cells in S-phase,and the growth curve of cells exhibited slower proliferation. Conclusion:The psilence 3.1-HER2 can knockdown her2/neu gene specially and efficiently,transfection of psilence 3.1-HER2 contributes to the depression of A549 cell proliferation. The data described here provided a proof of the concept that vector-based RNAi targeting to her2/neu gene could be used therapeutically for lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:The effect of HER2/neu expression on the proliferation of A549 cell is not clear. We inhibited the HER2/neu expression with RNA interference (RNAi) technique,and investigated the proliferation of A549 cell in this study. Methods:Firstly a recombinant RNAi expression plasmid targeting to her2/neu gene (named psilence 3.1-HER2) was constructed. After RNAi plasmids being transfected to A549 cells with Lipofectamine,the positive clones were screened with G418. The expression changes of HER2/neu mRNA and protein were evaluated with RT-PCR and Western Blot respectively; Also FCM analysis,MTT method were applied to measure cell cycle,cell growth of A549 cell respectively after the transfection of psilence 3.1-HER2. Results:The psilence 3.1-HER2 was successfully constructed and can specially inhibit HER2/neu mRNA and protein expression after transfection. FCM results showed that cells transfected with psilence 3.1-HER2 increased accumulation of cells in G0/G1 phase with a decrease in the percentage of cells in S-phase,and the growth curve of cells exhibited slower proliferation. Conclusion:The psilence 3.1-HER2 can knockdown her2/neu gene specially and efficiently,transfection of psilence 3.1-HER2 contributes to the depression of A549 cell proliferation. The data described here provided a proof of the concept that vector-based RNAi targeting to her2/neu gene could be used therapeutically for lung cancer.

Key concepts: Transfection, Lipofectamine, RNA interference, Molecular biology, Cell growth, A549 cell, Gene knockdown, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibition of A549 cell proliferation by RNA interfered gene her2/neu — Research Paper | ScholarLens